Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Merck
Boehringer Ingelheim
US Army
Fuji
Mallinckrodt
Julphar
Chinese Patent Office
Teva
Colorcon
Express Scripts

Generated: August 18, 2017

DrugPatentWatch Database Preview

Prazosin hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for prazosin hydrochloride and what is the scope of prazosin hydrochloride freedom to operate?

Prazosin hydrochloride
is the generic ingredient in three branded drugs marketed by Dava Pharms Inc, Watson Labs, Purepac Pharm, Pfizer, Teva Pharms, Mylan, Idt Australia Ltd, and Am Therap, and is included in seventeen NDAs. Additional information is available in the individual branded drug profile pages.

There are sixteen drug master file entries for prazosin hydrochloride. Eleven suppliers are listed for this compound.

Summary for Generic Name: prazosin hydrochloride

Tradenames:3
Patents:0
Applicants:8
NDAs:17
Drug Master File Entries: see list16
Suppliers / Packagers: see list11
Bulk Api Vendors: see list57
Clinical Trials: see list2,302
Patent Applications: see list2,124
Therapeutic Class:Genitourinary Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:prazosin hydrochloride at DailyMed

Pharmacology for Ingredient: prazosin hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dava Pharms Inc
PRAZOSIN HYDROCHLORIDE
prazosin hydrochloride
CAPSULE;ORAL072706-001May 16, 1989DISCNNoNo► Subscribe► Subscribe► Subscribe
Teva Pharms
PRAZOSIN HYDROCHLORIDE
prazosin hydrochloride
CAPSULE;ORAL071745-003Sep 12, 1988ABRXNoNo► Subscribe► Subscribe► Subscribe
Purepac Pharm
PRAZOSIN HYDROCHLORIDE
prazosin hydrochloride
CAPSULE;ORAL072992-001May 16, 1989DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
PRAZOSIN HYDROCHLORIDE
prazosin hydrochloride
CAPSULE;ORAL072609-001May 16, 1989DISCNNoNo► Subscribe► Subscribe► Subscribe
Am Therap
PRAZOSIN HYDROCHLORIDE
prazosin hydrochloride
CAPSULE;ORAL072784-001May 16, 1989DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: prazosin hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer
MINIPRESS XL
prazosin hydrochloride
TABLET, EXTENDED RELEASE;ORAL019775-002Jan 29, 1992► Subscribe► Subscribe
Pfizer
MINIPRESS
prazosin hydrochloride
CAPSULE;ORAL017442-003Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Pfizer
MINIPRESS XL
prazosin hydrochloride
TABLET, EXTENDED RELEASE;ORAL019775-002Jan 29, 1992► Subscribe► Subscribe
Pfizer
MINIPRESS XL
prazosin hydrochloride
TABLET, EXTENDED RELEASE;ORAL019775-001Jan 29, 1992► Subscribe► Subscribe
Pfizer
MINIPRESS XL
prazosin hydrochloride
TABLET, EXTENDED RELEASE;ORAL019775-002Jan 29, 1992► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

UBS
US Department of Justice
Baxter
Cipla
Daiichi Sankyo
Cerilliant
QuintilesIMS
US Army
Fuji
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot